Drug Trial Radar · NCT04739059
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
171
Actual
Start
Mar 29, 2021
Primary completion
Nov 21, 2025
Study completion Nov 21, 2025
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Feb 4, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase 3b study will evaluate long-term safety and efficacy of CSL312 (also known as garadacimab) when administered subcutaneously (SC)
Conditions
- Hereditary Angioedema
Interventions
CSL312Biological
Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-emergent Adverse Events (TEAE)Time frame: Approximately up to 54 months
- Percentage of Participants With TEAETime frame: Approximately up to 54 months
- Number of TEAETime frame: Approximately up to 54 months
- TEAE Rates Per InjectionTime frame: Approximately up to 54 months
- TEAE Rates Per Participant YearTime frame: Approximately up to 54 months
Locations
44 sites in 14 countries. Site status is shown where the registry gives one.
Clinical Research Center of Alabama
Birmingham, Alabama
Research Solutions of Arizona
Litchfield Park, Arizona
Medical Research of Arizona
Scottsdale, Arizona
Little Rock Allergy & Asthma Clinic
Little Rock, Arkansas
Donald S. Levy M.D.
Orange, California
Raffi Tachdjian MD, Inc.
Santa Monica, California
Allergy & Asthma Clinical Research
Walnut Creek, California
Institute for Asthma and Allergy PC
Chevy Chase, Maryland
Bernstein Clinical Research Center, LLC
Cincinnati, Ohio
PennState Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
AARA Research Center
Dallas, Texas
Campbelltown Hospital / Western Sydney University
Campbelltown, New South Wales, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Fiona Stanley Hospital, Department of Clinical Immunology
Murdoch, Western Australia, Australia
University of Alberta - Research Transition Facility
Edmonton, Alberta, Canada
McMaster University
Hamilton, Ontario, Canada
Ottawa Allergy Research Corp
Ottawa, Ontario, Canada
Gordon Sussman Clinical Research
Toronto, Ontario, Canada
Montreal Clinical Research Institute
Montreal, Quebec, Canada
University hospital St. Anna Ustav klinicke imunologie a alergologie, Fakultní nemocnice u sv. Anny v Brně
Brno, Czechia
University Hospital Motol
Prague, Czechia
Charité - Universitätsmedizin Berlin
Berlin, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Johannes Gutenberg-Universität KöR, Hautklinik und Poliklinik der Universitätsmedizin, Clinical Research Center
Mainz, Germany
HZRM Haemophilie Zentrum Rhein Main GmbH
Mörfelden-Walldorf, Germany
The University of Hong Kong, Queen Mary Hospital
Hong Kong, Hong Kong
Semmelweis Egyetem Altalanos Orvostudományi Kar Belgyógyászati és Hematológiai Klinika
Budapest, Hungary
Barzilai University Medical Center
Ashkelon, Israel
Koga Community Hospital
Shizuoka, Daikakuji Yaizu-shi, Japan
Mie University Hospital
Mie, Edobashi, Tsu-shi, Japan
Juntendo University Hospital
Tokyo, Hongo Bunkyo-ku, Japan
Saitama Medical Center
Saitama, Kamoda Kawagoe-shi, Japan
St. Marianna University School of Medicine Hospital
Kanagawa, Kawasaki-shi, Japan
Clover Hospital
Kanagawa, Kugenumaishigami, Fujisawa-shi, Japan
Saiyu Soka Hospital
Saitama, Matsubara Soka-shi, Japan
National Hospital Organization Disaster Medical Center
Tokyo, Midoricho, Tachikawa-shi, Japan
Saga University Hospital
Saga, Nebeshima, Saga-shi, Japan
Local Incorporated Administrative Agency Osaka City Hospital Organization Osaka City General Hospital
Miyakojima-ku, Osaka-shi, Japan
Amsterdam UMC, location AMC
Amsterdam, Netherlands
Auckland City Hospital
Grafton, Auckland, New Zealand
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.